| HOME | HELP | FEEDBACK | SUBSCRIPTIONS | ARCHIVE | SEARCH | TABLE OF CONTENTS |
| ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||

o * 
ska *


ski *
* Faculty of Chemistry, University of Gda
sk, Sobieskiego 18, 80-952 Gda
sk, Poland;
Baker Laboratory of Chemistry and Chemical Biology, Cornell University, Ithaca, New York 14853-1301; and
Universidad Nacional de San Luis, Facultad de Ciencias Físico Matemáticas y Naturales, Instituto de Matemática Aplicada San Luis, Consejo Nacional de Investigaciones Científicas y Técnicas, Ejército de los Andes, 950-5700 San Luis, Argentina
Correspondence: Address reprint requests to Harold A. Scheraga, Tel.: 607-255-4034; Fax: 607-254-254 4700; E-mail: has5{at}cornell.edu.
It has been suggested that the alanine-based peptide with sequence Ac-XX-[A]7-OO-NH2, termed XAO where X denotes diaminobutyric acid and O denotes ornithine, exists in a predominantly polyproline-helix (PII) conformation in aqueous solution. In our recent work, we demonstrated that this "polyproline conformation" should be regarded as a set of local conformational states rather than as the overall conformation of the molecule. In this work, we present further evidence to support this statement. Differential scanning calorimetry measurements showed only a very small peak in the heat capacity of an aqueous solution of XAO at 57°C, whereas the suggested transition to the PII structure should occur at
30°C. We also demonstrate that the temperature dependence of the 3JHNH
coupling constants of the alanine residues can be explained qualitatively in terms of Boltzmann averaging over all local conformational states; therefore, this temperature dependence proves that a conformational transition does not occur. Canonical MD simulations with the solvent represented by the generalized Born model, and with time-averaged NMR-derived restraints, demonstrate the presence of an ensemble of structures with a substantial amount of local PII conformational states but not with an overall PII conformation.
| HOME | HELP | FEEDBACK | SUBSCRIPTIONS | ARCHIVE | SEARCH | TABLE OF CONTENTS |